Digest Network How does it work
Network
/
Society
en
Not verified

enGene Holdings Inc.

What we write about

BiotechnologyHealthMedicine - variousPharmaceuticalsScienza

41 Press releases

View all press releases
13/11/2025
Finance
Health
Biotechnology
enGene Announces Pricing of $130 Million Public Offering of Common Shares and Pre-Funded Warrants
Source
enGene Holdings Inc.
Issuer
Business Wire
1.00
0
12/11/2025
Health
Biotechnology
Medicine - various
Scienza
Pharmaceuticals
Finance
enGene Announces Proposed Public Offering of Common Shares
Source
enGene Holdings Inc.
Issuer
Business Wire
1.00
0
11/11/2025
WEB AND SOCIAL NETWORK
Phones and Miscellaneous
Finance
Industria
Oncology
Health
Medicine - various
Scienza
Pharmaceuticals
Biotechnology
Detalimogene Demonstrates Improved Complete Response Rate of 62% at 6 Months
Source
enGene Holdings Inc.
Issuer
Business Wire
1.00
0
10/11/2025
WEB AND SOCIAL NETWORK
Phones and Miscellaneous
Industria
Scienza
Biotechnology
Medicine - various
Health
Pharmaceuticals
Sanità
Oncology
enGene to Host Conference Call to Provide Update on Pivotal Cohort of LEGEND Trial
Source
enGene Holdings Inc.
Issuer
Business Wire
1.00
0
06/11/2025
Scienza
Biotechnology
Pharmaceuticals
Sanità
Health
Medicine - various
Eventi
WEB AND SOCIAL NETWORK
enGene to Participate in Upcoming Investor Conferences
Source
enGene Holdings Inc.
Issuer
Business Wire
1.00
0
04/11/2025
Scienza
Biotechnology
Medicine - various
Health
Pharmaceuticals
Sanità
Oncology
Eventi
enGene Named a BioSpace 2026 Best Places to Work Winner
Source
enGene Holdings Inc.
Issuer
Business Wire
1.00
0
01/10/2025
stock market
Finance
Health
Biotechnology
Sanità
Medicine - various
Scienza
enGene Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Source
enGene Holdings Inc.
Issuer
Business Wire
1.00
0
30/09/2025
Labour market
Oncology
Health
Biotechnology
Medicine - various
Pharmaceuticals
enGene Appoints Hussein Sweiti, M.D., MSc, as Chief Medical Officer
Source
enGene Holdings Inc.
Issuer
Business Wire
1.00
0
11/09/2025
stock market
Scienza
Biotechnology
Pharmaceuticals
Oncology
Health
Medicine - various
enGene Reports Third Quarter 2025 Financial Results and Provides Business Update
Source
enGene Holdings Inc.
Issuer
Business Wire
1.00
0
03/09/2025
Industria
Scienza
Food hygiene
Biotechnology
Medicine - various
Pharmaceuticals
Health
Oncology
enGene Achieves Target Enrollment Milestone for LEGEND Trial Pivotal Cohort
Source
enGene Holdings Inc.
Issuer
Business Wire
1.00
0

Contact details

Social Media

Followers
0
Compatibility
0